Report highlights progress and challenges in Latin American healthcare

1 March 2024

rio_brazil_brasil_latin_south_america_large

A new report has provided an overview of the state of healthcare in Latin America and its nations, reports The Pharma Letter's local correspondent.

The Health Innovation Outlook (HIO) report has been produced through a collaboration involving FIFARMA, the Latin American Federation of the Pharmaceutical Industry, the Institute of Prospective and Innovation in Health (INNOS) and El Bosque University of Colombia.

The analysis looks at performance in seven areas and 48 health indicators and innovation, and compares them with global benchmarks.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK